|
US6267958B1
(en)
*
|
1995-07-27 |
2001-07-31 |
Genentech, Inc. |
Protein formulation
|
|
EP1864999B1
(en)
*
|
1996-11-27 |
2009-03-18 |
Genentech, Inc. |
Affinity purification of polypeptide on protein a matrix
|
|
ATE321066T1
(de)
*
|
1998-05-06 |
2006-04-15 |
Genentech Inc |
Anti-her2 antikörperzusammensetzung
|
|
US20030086924A1
(en)
*
|
1999-06-25 |
2003-05-08 |
Genentech, Inc. |
Treatment with anti-ErbB2 antibodies
|
|
US6949245B1
(en)
*
|
1999-06-25 |
2005-09-27 |
Genentech, Inc. |
Humanized anti-ErbB2 antibodies and treatment with anti-ErbB2 antibodies
|
|
AU2001259271A1
(en)
*
|
2000-04-28 |
2001-11-12 |
Millennium Pharmaceuticals, Inc. |
14094, a novel human trypsin family member and uses thereof
|
|
US20020119148A1
(en)
*
|
2000-09-01 |
2002-08-29 |
Gerritsen Mary E. |
ErbB4 antagonists
|
|
DE60213248T2
(de)
|
2001-06-05 |
2006-11-30 |
Genetics Institute, LLC, Cambridge |
Verfahren zur reinigung hochanionischer proteine
|
|
US7452539B2
(en)
*
|
2001-12-19 |
2008-11-18 |
Genentech, Inc. |
Stabilizing polypeptides which have been exposed to urea
|
|
WO2003059935A2
(en)
*
|
2001-12-21 |
2003-07-24 |
Immunex Corporation |
Methods for purifying protein
|
|
AU2003210802B2
(en)
*
|
2002-02-05 |
2009-09-10 |
Genentech Inc. |
Protein purification
|
|
ES2558303T3
(es)
|
2002-09-11 |
2016-02-03 |
Chugai Seiyaku Kabushiki Kaisha |
Método de purificación de proteínas
|
|
ES2629602T5
(es)
|
2002-09-11 |
2021-06-08 |
Genentech Inc |
Purificación de proteínas
|
|
WO2005000901A2
(en)
*
|
2003-05-09 |
2005-01-06 |
Duke University |
Cd20-specific antibodies and methods of employing same
|
|
ES2786568T3
(es)
*
|
2003-07-28 |
2020-10-13 |
Genentech Inc |
Reducción de la lixiviación de la proteína A durante la cromatografía de afinidad con proteína A
|
|
US20050065136A1
(en)
*
|
2003-08-13 |
2005-03-24 |
Roby Russell R. |
Methods and compositions for the treatment of infertility using dilute hormone solutions
|
|
WO2005019434A2
(en)
|
2003-08-26 |
2005-03-03 |
The Regents Of The University Of Colorado, A Body Corporate |
Serine protease inhibitors for treatment of bacterial infections
|
|
WO2005037869A2
(en)
*
|
2003-10-15 |
2005-04-28 |
Applera Corporation |
Method of reducing leachate from protein a affinity media
|
|
WO2005045058A2
(en)
*
|
2003-10-27 |
2005-05-19 |
Monogram Biosciences, Inc. |
Detecting human anti-therapeutic antibodies
|
|
EA036531B1
(ru)
|
2003-11-05 |
2020-11-19 |
Роше Гликарт Аг |
Гуманизированное антитело типа ii к cd20 (варианты), фармацевтическая композиция, содержащая эти варианты антитела, и их применение
|
|
US20050239757A1
(en)
*
|
2004-04-21 |
2005-10-27 |
Roby Russell R |
Hormone treatment of macular degeneration
|
|
JO3000B1
(ar)
|
2004-10-20 |
2016-09-05 |
Genentech Inc |
مركبات أجسام مضادة .
|
|
EP3698807A1
(en)
|
2005-01-21 |
2020-08-26 |
Genentech, Inc. |
Fixed dosing of her antibodies
|
|
CA2595395A1
(en)
*
|
2005-02-09 |
2006-08-17 |
Genentech, Inc. |
Inhibiting her2 shedding with matrix metalloprotease antagonists
|
|
AU2006216732C1
(en)
|
2005-02-23 |
2017-07-20 |
Genentech, Inc. |
Extending time to disease progression or survival in cancer patients using a HER dimerization inhibitor
|
|
JP2008538112A
(ja)
*
|
2005-03-23 |
2008-10-09 |
バイオ−ラッド ラボラトリーズ インコーポレーティッド |
常磁性特性を持つ小粒子に結合した、多様な化学ライブラリー
|
|
US20090247421A1
(en)
*
|
2005-03-23 |
2009-10-01 |
Egisto Boschetti |
Diverse chemical libraries bound to small particles with paramagnetic properties
|
|
JP2006316040A
(ja)
|
2005-05-13 |
2006-11-24 |
Genentech Inc |
Ｈｅｒｃｅｐｔｉｎ（登録商標）補助療法
|
|
PE20070207A1
(es)
*
|
2005-07-22 |
2007-03-09 |
Genentech Inc |
Tratamiento combinado de los tumores que expresan el her
|
|
JP2009513708A
(ja)
*
|
2005-10-31 |
2009-04-02 |
オンコメッド ファーマシューティカルズ インコーポレイテッド |
癌の診断および処置のための組成物および方法
|
|
US7723477B2
(en)
|
2005-10-31 |
2010-05-25 |
Oncomed Pharmaceuticals, Inc. |
Compositions and methods for inhibiting Wnt-dependent solid tumor cell growth
|
|
PL2253644T3
(pl)
|
2005-12-20 |
2014-04-30 |
Bristol Myers Squibb Co |
Kompozycje i sposoby wytwarzania kompozycji
|
|
AR058568A1
(es)
|
2005-12-20 |
2008-02-13 |
Bristol Myers Squibb Co |
Metodos para producir una composicion con moleculas ctla4-ig a partir de un medio de cultivo
|
|
WO2007081906A2
(en)
*
|
2006-01-06 |
2007-07-19 |
Amgen Inc. |
Purification by column-chromatography using eluants containing organic solvents
|
|
US8263750B2
(en)
*
|
2006-03-16 |
2012-09-11 |
Amgen Inc. |
Method for purifying a protein using protein-A affinity chromatography using an intermediate wash step
|
|
FR2902799B1
(fr)
|
2006-06-27 |
2012-10-26 |
Millipore Corp |
Procede et unite de preparation d'un echantillon pour l'analyse microbiologique d'un liquide
|
|
CN101511387A
(zh)
*
|
2006-09-08 |
2009-08-19 |
惠氏公司 |
使用亲和色谱法纯化蛋白质的精氨酸洗涤液
|
|
US8911964B2
(en)
|
2006-09-13 |
2014-12-16 |
Abbvie Inc. |
Fed-batch method of making human anti-TNF-alpha antibody
|
|
AU2007294731B2
(en)
|
2006-09-13 |
2014-04-17 |
Abbvie Inc. |
Cell culture improvements
|
|
US8853371B2
(en)
*
|
2006-10-19 |
2014-10-07 |
Janssen Biotech, Inc. |
Process for preparing unaggregated antibody Fc domains
|
|
WO2008079280A1
(en)
*
|
2006-12-21 |
2008-07-03 |
Millipore Corporation |
Purification of proteins
|
|
US8569464B2
(en)
|
2006-12-21 |
2013-10-29 |
Emd Millipore Corporation |
Purification of proteins
|
|
US8362217B2
(en)
*
|
2006-12-21 |
2013-01-29 |
Emd Millipore Corporation |
Purification of proteins
|
|
ES2426158T3
(es)
|
2007-01-22 |
2013-10-21 |
Genentech, Inc. |
Precipitación con polielectrolito y purificación de anticuerpos
|
|
US20100063257A1
(en)
*
|
2007-01-26 |
2010-03-11 |
Merck Serono Sa |
Purification of FC-TACI Fusion Proteins Using the Oilbody Technology
|
|
WO2008109440A2
(en)
|
2007-03-02 |
2008-09-12 |
Genentech, Inc. |
Predicting response to a her dimerisation inhibitor based on low her3 expression
|
|
WO2008154249A2
(en)
*
|
2007-06-08 |
2008-12-18 |
Genentech, Inc. |
Gene expression markers of tumor resistance to her2 inhibitor treatment
|
|
US9551033B2
(en)
*
|
2007-06-08 |
2017-01-24 |
Genentech, Inc. |
Gene expression markers of tumor resistance to HER2 inhibitor treatment
|
|
SI3597659T1
(sl)
*
|
2007-07-09 |
2023-04-28 |
Genentech, Inc. |
Preprečevanje redukcije disulfidne vezi med rekombinantno proizvodnjo polipeptidov
|
|
RS53850B2
(sr)
|
2007-10-30 |
2018-07-31 |
Genentech Inc |
Pročišćavanje antitela hromatografijom izmene katjona
|
|
TWI472339B
(zh)
*
|
2008-01-30 |
2015-02-11 |
Genentech Inc |
包含結合至ｈｅｒ２結構域ii之抗體及其酸性變異體的組合物
|
|
US8999702B2
(en)
*
|
2008-06-11 |
2015-04-07 |
Emd Millipore Corporation |
Stirred tank bioreactor
|
|
BRPI0812682A2
(pt)
|
2008-06-16 |
2010-06-22 |
Genentech Inc |
tratamento de cáncer de mama metastático
|
|
TW201014605A
(en)
|
2008-09-16 |
2010-04-16 |
Genentech Inc |
Methods for treating progressive multiple sclerosis
|
|
AU2009296246B2
(en)
|
2008-09-26 |
2015-07-30 |
Oncomed Pharmaceuticals, Inc. |
Frizzled-binding agents and uses thereof
|
|
JP5856845B2
(ja)
|
2008-10-20 |
2016-02-10 |
アッヴィ・インコーポレイテッド |
抗体精製中におけるウイルスの不活性化
|
|
CA2932207A1
(en)
|
2008-10-20 |
2010-12-09 |
Abbvie Inc. |
Isolation and purification of antibodies using protein a affinity chromatography
|
|
CN105037535A
(zh)
|
2008-12-16 |
2015-11-11 |
Emd密理博公司 |
搅拌槽反应器及方法
|
|
US8846878B1
(en)
*
|
2009-01-23 |
2014-09-30 |
Cubrc Corporation |
Method and device for isolating a protein sample
|
|
ES2572728T3
(es)
|
2009-03-20 |
2016-06-02 |
F. Hoffmann-La Roche Ag |
Anticuerpos anti-HER biespecíficos
|
|
JP5705836B2
(ja)
|
2009-05-29 |
2015-04-22 |
エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト |
Ｈｅｒ２を発現する胃癌患者のｈｅｒ２シグナル伝達のためのモジュレーター
|
|
CA2768325C
(en)
*
|
2009-07-24 |
2019-10-29 |
F. Hoffmann-La Roche Ag |
Optimizing the production of antibodies
|
|
AR078161A1
(es)
|
2009-09-11 |
2011-10-19 |
Hoffmann La Roche |
Formulaciones farmaceuticas muy concentradas de un anticuerpo anti cd20. uso de la formulacion. metodo de tratamiento.
|
|
WO2011038894A1
(en)
|
2009-10-01 |
2011-04-07 |
F. Hoffmann-La Roche Ag |
Protein a chromatography
|
|
HUE030186T2
(en)
|
2009-10-01 |
2017-04-28 |
Hoffmann La Roche |
Multiple-step final screening for immunoglobulin
|
|
NZ600278A
(en)
|
2009-11-13 |
2014-04-30 |
Grifols Therapeutics Inc |
Von willebrand factor (vwf)-containing preparations, and methods, kits, and uses related thereto
|
|
WO2011073389A1
(en)
|
2009-12-18 |
2011-06-23 |
Novartis Ag |
Wash solution and method for affinity chromatography
|
|
TWI535445B
(zh)
|
2010-01-12 |
2016-06-01 |
安可美德藥物股份有限公司 |
Ｗｎｔ拮抗劑及治療和篩選方法
|
|
JP5981853B2
(ja)
|
2010-02-18 |
2016-08-31 |
ジェネンテック， インコーポレイテッド |
ニューレグリンアンタゴニスト及び癌の治療におけるそれらの使用
|
|
CN102971337B
(zh)
|
2010-04-01 |
2016-09-21 |
昂考梅德药品有限公司 |
卷曲蛋白结合药剂及其应用
|
|
EP2571903B1
(en)
|
2010-05-17 |
2019-09-04 |
EMD Millipore Corporation |
Stimulus responsive polymers for the purification of biomolecules
|
|
WO2011146568A1
(en)
|
2010-05-19 |
2011-11-24 |
Genentech, Inc. |
Predicting response to a her inhibitor
|
|
GB201012603D0
(en)
|
2010-07-27 |
2010-09-08 |
Ucb Pharma Sa |
Protein purification
|
|
EP2643353A1
(en)
|
2010-11-24 |
2013-10-02 |
Novartis AG |
Multispecific molecules
|
|
EP2652491B1
(en)
|
2010-12-15 |
2017-11-29 |
Baxalta GmbH |
Eluate collection using conductivity gradient
|
|
SG191153A1
(en)
|
2010-12-23 |
2013-07-31 |
Hoffmann La Roche |
Polypeptide-polynucleotide-complex and its use in targeted effector moiety delivery
|
|
EP2702077A2
(en)
|
2011-04-27 |
2014-03-05 |
AbbVie Inc. |
Methods for controlling the galactosylation profile of recombinantly-expressed proteins
|
|
KR20200044138A
(ko)
|
2011-06-24 |
2020-04-28 |
더 리젠츠 오브 더 유니버시티 오브 콜로라도, 어 바디 코포레이트 |
알파-1 안티트립신 융합 분자용 조성물, 방법 및 용도
|
|
MX2014001766A
(es)
|
2011-08-17 |
2014-05-01 |
Genentech Inc |
Anticuerpos de neuregulina y sus usos.
|
|
DK2766040T3
(da)
|
2011-10-14 |
2019-07-22 |
Hoffmann La Roche |
Pertuzumab, trastuzumab, docetaxel og carboplatin til behandling af brystkræft i et tidligt stadie
|
|
WO2013063229A1
(en)
|
2011-10-25 |
2013-05-02 |
The Regents Of The University Of Michigan |
Her2 targeting agent treatment in non-her2-amplified cancers having her2 expressing cancer stem cells
|
|
JP6356607B2
(ja)
*
|
2011-11-02 |
2018-07-11 |
ジェネンテック， インコーポレイテッド |
オーバーロード／溶出クロマトグラフィー
|
|
CA2857114A1
(en)
|
2011-11-30 |
2013-06-06 |
Genentech, Inc. |
Erbb3 mutations in cancer
|
|
WO2013083810A1
(en)
|
2011-12-09 |
2013-06-13 |
F. Hoffmann-La Roche Ag |
Identification of non-responders to her2 inhibitors
|
|
CA2896951A1
(en)
|
2012-01-10 |
2013-07-18 |
The Regents Of The University Of Colorado, A Body Corporate |
Compositions, methods and uses for alpha-1 antitrypsin fusion molecules
|
|
JP2015514710A
(ja)
|
2012-03-27 |
2015-05-21 |
ジェネンテック， インコーポレイテッド |
Ｈｅｒ３阻害剤に関する診断及び治療
|
|
ES2567091T3
(es)
*
|
2012-04-05 |
2016-04-19 |
F. Hoffmann-La Roche Ag |
Compuestos de amina para la preparación selectiva de muestras biológicas
|
|
US9067990B2
(en)
|
2013-03-14 |
2015-06-30 |
Abbvie, Inc. |
Protein purification using displacement chromatography
|
|
US9150645B2
(en)
|
2012-04-20 |
2015-10-06 |
Abbvie, Inc. |
Cell culture methods to reduce acidic species
|
|
US9181572B2
(en)
|
2012-04-20 |
2015-11-10 |
Abbvie, Inc. |
Methods to modulate lysine variant distribution
|
|
WO2013177115A2
(en)
*
|
2012-05-21 |
2013-11-28 |
Abbvie Inc. |
Novel purification of human, humanized, or chimeric antibodies using protein a affinity chromatography
|
|
WO2013176754A1
(en)
|
2012-05-24 |
2013-11-28 |
Abbvie Inc. |
Novel purification of antibodies using hydrophobic interaction chromatography
|
|
KR20150043523A
(ko)
|
2012-09-02 |
2015-04-22 |
애브비 인코포레이티드 |
단백질 불균일성의 제어 방법
|
|
US9512214B2
(en)
|
2012-09-02 |
2016-12-06 |
Abbvie, Inc. |
Methods to control protein heterogeneity
|
|
CA2885263C
(en)
|
2012-09-17 |
2021-11-16 |
W. R. Grace & Co.-Conn. |
Chromatography media and devices
|
|
MY195756A
(en)
|
2012-09-17 |
2023-02-09 |
Grace W R & Co |
Functionalized Particulate Support Material and Methods of Making and Using the Same
|
|
CA2887711A1
(en)
|
2012-10-23 |
2014-05-01 |
Oncomed Pharmaceuticals, Inc. |
Methods of treating neuroendocrine tumors using wnt pathway-binding agents
|
|
MX363188B
(es)
|
2012-11-30 |
2019-03-13 |
Hoffmann La Roche |
Identificación de pacientes con necesidad de coterapia del inhibidor de pd-l1.
|
|
CN105073195A
(zh)
|
2013-02-04 |
2015-11-18 |
昂科梅德制药有限公司 |
使用Wnt途径抑制剂进行治疗的方法及对该治疗的监测
|
|
WO2014137903A2
(en)
|
2013-03-08 |
2014-09-12 |
Genzyme Corporation |
Integrated continuous manufacturing of therapeutic protein drug substances
|
|
EP2830651A4
(en)
|
2013-03-12 |
2015-09-02 |
Abbvie Inc |
HUMAN ANTIBODIES THAT BIND TNF-ALPHA AND PREPARATION METHODS
|
|
US9017687B1
(en)
|
2013-10-18 |
2015-04-28 |
Abbvie, Inc. |
Low acidic species compositions and methods for producing and using the same using displacement chromatography
|
|
WO2014151878A2
(en)
|
2013-03-14 |
2014-09-25 |
Abbvie Inc. |
Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using monosaccharides and oligosacharides
|
|
US9168300B2
(en)
|
2013-03-14 |
2015-10-27 |
Oncomed Pharmaceuticals, Inc. |
MET-binding agents and uses thereof
|
|
WO2014159579A1
(en)
|
2013-03-14 |
2014-10-02 |
Abbvie Inc. |
MUTATED ANTI-TNFα ANTIBODIES AND METHODS OF THEIR USE
|
|
AR095863A1
(es)
|
2013-04-16 |
2015-11-18 |
Genentech Inc |
Variantes de pertuzumab, su evaluación, método de tratamiento, método de preparación y artículo de fabricación
|
|
JP6147340B2
(ja)
*
|
2013-05-29 |
2017-06-14 |
Jsr株式会社 |
洗浄用組成物、タンパク質精製方法、及びタンパク質
|
|
EP3019262A1
(en)
*
|
2013-07-12 |
2016-05-18 |
Merck Patent GmbH |
Removal of fragments from a sample containing a target protein using activated carbon
|
|
RU2016107435A
(ru)
|
2013-09-13 |
2017-10-18 |
Дженентек, Инк. |
Композиции и способы обнаружения и количественного определения белка клеток-хозяев в клеточных линиях и рекомбинантные полипептидные продукты
|
|
NZ756749A
(en)
|
2013-09-13 |
2022-05-27 |
Genentech Inc |
Methods and compositions comprising purified recombinant polypeptides
|
|
US9598667B2
(en)
|
2013-10-04 |
2017-03-21 |
Abbvie Inc. |
Use of metal ions for modulation of protein glycosylation profiles of recombinant proteins
|
|
US8946395B1
(en)
|
2013-10-18 |
2015-02-03 |
Abbvie Inc. |
Purification of proteins using hydrophobic interaction chromatography
|
|
US9085618B2
(en)
|
2013-10-18 |
2015-07-21 |
Abbvie, Inc. |
Low acidic species compositions and methods for producing and using the same
|
|
US9181337B2
(en)
|
2013-10-18 |
2015-11-10 |
Abbvie, Inc. |
Modulated lysine variant species compositions and methods for producing and using the same
|
|
WO2015073884A2
(en)
|
2013-11-15 |
2015-05-21 |
Abbvie, Inc. |
Glycoengineered binding protein compositions
|
|
WO2015103545A1
(en)
|
2014-01-03 |
2015-07-09 |
Bio-Rad Laboratories, Inc. |
Removal of impurities from protein a eluates
|
|
JP6853670B2
(ja)
|
2014-01-16 |
2021-04-07 |
ダブリュー・アール・グレース・アンド・カンパニー−コーンＷ Ｒ Ｇｒａｃｅ ＆ Ｃｏ−Ｃｏｎｎ |
親和性クロマトグラフィー媒体及びクロマトグラフィーデバイス
|
|
TWI709569B
(zh)
|
2014-01-17 |
2020-11-11 |
美商健臻公司 |
無菌層析樹脂及其用於製造方法的用途
|
|
TWI671312B
(zh)
|
2014-01-17 |
2019-09-11 |
美商健臻公司 |
無菌層析法及製法
|
|
EP3134440A1
(en)
|
2014-04-25 |
2017-03-01 |
F. Hoffmann-La Roche AG |
Methods of treating early breast cancer with trastuzumab-mcc-dm1 and pertuzumab
|
|
WO2015168383A1
(en)
|
2014-05-02 |
2015-11-05 |
W. R. Grace & Co.-Conn. |
Functionalized support material and methods of making and using functionalized support material
|
|
US11566082B2
(en)
|
2014-11-17 |
2023-01-31 |
Cytiva Bioprocess R&D Ab |
Mutated immunoglobulin-binding polypeptides
|
|
EP3302551A2
(en)
|
2015-05-30 |
2018-04-11 |
H. Hoffnabb-La Roche Ag |
Methods of treating her2-positive locally advanced or previously untreated metastatic breast cancer
|
|
SG10201911134QA
(en)
|
2015-06-05 |
2020-01-30 |
Grace W R & Co |
Adsorbent bioprocessing clarification agents and methods of making and using the same
|
|
WO2017087280A1
(en)
|
2015-11-16 |
2017-05-26 |
Genentech, Inc. |
Methods of treating her2-positive cancer
|
|
EP3454863A1
(en)
|
2016-05-10 |
2019-03-20 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Combinations therapies for the treatment of cancer
|
|
US10889615B2
(en)
|
2016-05-11 |
2021-01-12 |
Cytiva Bioprocess R&D Ab |
Mutated immunoglobulin-binding polypeptides
|
|
US10703774B2
(en)
|
2016-09-30 |
2020-07-07 |
Ge Healthcare Bioprocess R&D Ab |
Separation method
|
|
ES2874974T3
(es)
|
2016-05-11 |
2021-11-05 |
Cytiva Bioprocess R & D Ab |
Matriz de separación
|
|
ES2909833T3
(es)
|
2016-05-11 |
2022-05-10 |
Cytiva Bioprocess R & D Ab |
Método de limpieza y/o desinfección de una matriz de separación
|
|
CN109311949B
(zh)
|
2016-05-11 |
2022-09-16 |
思拓凡生物工艺研发有限公司 |
储存分离基质的方法
|
|
US10654887B2
(en)
|
2016-05-11 |
2020-05-19 |
Ge Healthcare Bio-Process R&D Ab |
Separation matrix
|
|
US10730908B2
(en)
|
2016-05-11 |
2020-08-04 |
Ge Healthcare Bioprocess R&D Ab |
Separation method
|
|
WO2018045587A1
(zh)
*
|
2016-09-12 |
2018-03-15 |
广东东阳光药业有限公司 |
一种抗vegf类单克隆抗体的纯化方法
|
|
JP2019532999A
(ja)
|
2016-11-04 |
2019-11-14 |
ジェネンテック， インコーポレイテッド |
Ｈｅｒ２陽性乳がんの治療
|
|
CN110099926A
(zh)
|
2016-12-28 |
2019-08-06 |
豪夫迈·罗氏有限公司 |
晚期her2表达性癌症的治疗
|
|
RU2750821C2
(ru)
|
2017-01-17 |
2021-07-05 |
Дженентек, Инк. |
Препараты антител против her2 для подкожного введения
|
|
FI3589661T3
(fi)
|
2017-03-02 |
2024-01-31 |
Genentech Inc |
Her2-positiivisen rintasyövän adjuvanttihoito
|
|
CN110536969A
(zh)
|
2017-04-24 |
2019-12-03 |
豪夫迈·罗氏有限公司 |
跨膜或近膜域中的erbb2/her2突变
|
|
DK3668985T3
(da)
|
2017-08-17 |
2021-09-20 |
Just Evotec Biologics Inc |
Fremgangsmåde til rensning af glycosyleret protein fra værtscellegalectiner og andre urenheder
|
|
WO2020046602A1
(en)
|
2018-08-31 |
2020-03-05 |
Genzyme Corporation |
Sterile chromatography resin and use thereof in manufacturing processes
|
|
WO2020206138A1
(en)
|
2019-04-02 |
2020-10-08 |
Bondwell Technologies Inc. |
Functionalized ubx protein materials for enhanced purification of antibodies
|